Costs of chronic disease management for newly insured adults

Medical Care

Volumn 49, Issue 9, 2011, Pages

  Gilmer, Todd ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

costs; diabetes; disease management; hypertension

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; HYPERTENSION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; OUTPATIENT CARE; PRIORITY JOURNAL; SCORING SYSTEM;

CALIFORNIA; CHRONIC DISEASE; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HEALTH CARE COSTS; HUMANS; HYPERTENSION; INSURANCE COVERAGE; LINEAR MODELS; MALE; MEDICAL ASSISTANCE; MIDDLE AGED; MODELS, ECONOMETRIC; PATIENT PROTECTION AND AFFORDABLE CARE ACT; POVERTY; PROPENSITY SCORE; SELF CARE; UNITED STATES;

EID: 80052141105     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e318215d280     Document Type: Article

References (28)

1. Congressional Budget Office. Preliminary estimate of the direct spending and revenue effects of an amendment in the nature of a substitute to H.R. 4872, the Reconciliation Act of 2010.
2. Wilper AP, Woolhandler S, Lasser KE, et al. A national study of chronic disease prevalence and access to care in uninsured US adults. Ann Intern Med. 2008;149:170-176.
3. Kaiser Family Foundation. Focus on health reform: Summary of new health reform law.
4. Norris SL, Nichols PJ, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med. 2002;22(4 suppl):15-38. (Pubitemid 34436884)
5. Piette JD, Weinberger M, Kraemer FB, et al. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. Diabetes Care. 2001;24:202-208. (Pubitemid 32119112)
6. Bu D, Pan E, Walker J, et al. Benefits of information technologyenabled diabetes management. Diabetes Care. 2007;30:1137-1142. (Pubitemid 46684638)
7. Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a metaregression analysis. JAMA. 2006;296:427-440. (Pubitemid 44127527)
8. Gilmer TP, Philis-Tsimikas A, Walker C. Outcomes of Project Dulce: a culturally specific diabetes management program. Ann Pharmacother. 2005;39:817-822. (Pubitemid 40570658)
9. Sidorov J, Shull R, Tomcavage J, et al. Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria. Diabetes Care. 2002;25:684-689. (Pubitemid 41071187)
10. Scanlon DP, Hollenbeak CS, Beich J, et al. Financial and clinical impact of team-based treatment for medicaid enrollees with diabetes in a federally qualified health center. Diabetes Care. 2008;31:2160-2165.
11. CDC Diabetes Cost-effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. The CDC Diabetes Costeffectiveness Group. JAMA. 2002;287:2542-2551.
12. Gilmer T, Roze S, Valentine W, et al. Cost-effectiveness of diabetes case management for low-income populations. Health Serv Res. 2007;42:1943-1959. (Pubitemid 47397181)
13. Huang ES, Zhang Q, Brown SE, et al. The cost-effectiveness of improving diabetes care in US federally qualified community health centers. Health Serv Res. 2007;42(6 Pt 1):2174-2193; discussion 2294-2323. (Pubitemid 350077336)
14. Wilper AP, Woolhandler S, Lasser KE, et al. Hypertension, diabetes, and elevated cholesterol among insured and uninsured US adults. Health Aff (Millwood). 2009;28:w1151-w1159.
15. Mazze RS, Etzwiler DD, Strock E, et al. Staged diabetes management. Toward an integrated model of diabetes care. Diabetes Care. 1994;17(suppl 1):56-66. (Pubitemid 24162005)
16. American Diabetes Association. Clinical practice recommendations 2003. Diabetes Care. 2003;26(suppl 1):S1-S156.
17. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572. (Pubitemid 37430158)
18. Johnson N KS, Balakrishnan N. Continuous Univariate Distributions. Vol 1. 2nd ed. New York, NY: Wiley; 1994.
19. Mullahy J. Heterogeneity, excess zeros, and the structure of count data models. J Appl Econom. 1997;12:337-350.
20. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461-494. (Pubitemid 32515166)
21. Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ. 1999;18:153-171. (Pubitemid 29052479)
22. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley; 1989.
23. Pregibon D. Goodness of link tests for generalized linear models. Appl Stat. 1980;29:15-24.
24. Manning WG, Newhouse JP, Duan N, et al. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev. 1987;77:251-277.
25. Kronick R, Gilmer T, Dreyfus T, et al. Improving health-based payment for Medicaid beneficiaries: CDPS. Health Care Financ Rev. 2000;21:29-64. Spring.
26. Basu A, Polsky D, Manning WG. Use of Propensity Scores in Nonlinear Response Models: The Case for Health Care Expenditures. NBER Working Paper. Cambridge, MA: National Bureau of Economic Research; 2008.
27. Becker SO, Ichino A. Estimation of average treatment effects based on propensity scores. Stata J. 2002;2:358-377.
28. Efron B. An Introduction to the Bootstrap. New York, NY: Chapman and Hall; 1993.